Nuvig Therapeutics (Series B)

Funding Details
Awarder
Inbox
Date Award
December 06, 2024
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$161,000,000

Company Info
Founders
Pamela Conley
Company Description
Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.
Market
Chronic inflammatory and autoimmune diseases
Location
Menlo Park, California, USA
Coinvestors
abrdn, Alexandria Venture Investments, B Capital, Blue Owl, Bristol Myers Squibb, Digitalis Ventures, Global BioAccess Fund, Leaps by Bayer, LOTTE Holdings, Mission BioCapital, Norwest Venture Partners, Novo Holdings, Platanus, Sanofi Ventures

Links